The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events

.

Source: Expert Opinion on Drug Metabolism and Toxicology - October 4, 2021 Category: Drugs & Pharmacology Authors: Abimael Gonz ález-Hernández Bruno A. Marichal-Cancino Carlos M. Villal ón Source Type: research